Swadeshi Jagran Manch (SJM) has asked the government to revoke the patent granted to Gilead Sciences for Remdesivsir, a crucial medicine used in the treatment of Covid-19, so that it becomes more affordable.
In a letter written by SJM’s national co-convener Ashwani Mahajan Wednesday, the group requested Modi to initiate measures “under Section 66 of the Patents Act for the cancelation of the patent on Remdesivir, which was granted against the provisions of the Indian Patents Act”.
This move from the organisation – that promotes national sel ..
